Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
40.60
-0.51 (-1.24%)
At close: Jun 13, 2025, 4:00 PM
40.59
-0.01 (-0.02%)
After-hours: Jun 13, 2025, 5:50 PM EDT
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $7.56 billion as of June 13, 2025. Its market cap has increased by 20.94% in one year.
Market Cap
7.56B
Enterprise Value
5.59B
1-Year Change
20.94%
Ranking
Category
Stock Price
$40.60
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $7.56B, an increase of 359.87%. That is a compound annual growth rate of 33.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2025 | 7.66B | -5.26% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | 2.63B | 59.81% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 731.97B |
| Johnson & Johnson | 374.43B |
| Novo Nordisk | 353.21B |
| AbbVie | 333.86B |
| UnitedHealth Group | 287.45B |
| Abbott Laboratories | 236.30B |
| Novartis AG | 231.84B |
| AstraZeneca | 229.07B |